Yushan Boi, Tan Benjamin Y Q, Ngiam Nicholas Jinghao, Chan Bernard P L, Luen Teoh Hock, Sharma Vijay K, Sia Ching-Hui, Dalakoti Mayank, Chong Seow Swee, Kojodjojo Pipin, Yeo Leonard L L
National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.
National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.
J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2448-2452. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.025. Epub 2019 Jul 13.
Increasingly, insertable cardiac monitors (ICM) have been used to detect Atrial Fibrillation (AF) in patients with cryptogenic stroke or embolic strokes of undetermined source (ESUS). We aim to examine the characteristics of these patients who were subsequently found to have AF.
We studied 83 consecutive patients who were comprehensively evaluated using neuroimaging and vessel imaging (computed tomography angiography, magnetic resonance angiography, or transcranial and extracranial Doppler sonography) to have met the previously established ESUS criteria. All 83 patients had ICM implanted between 2015 and 2017. All patients were followed up for at least 1 year, with a median follow-up period of 1.5 ± .5 years. We compared the baseline clinical, laboratory, echocardiographic, neuro-imaging profiles, and clinical outcomes in terms of functional recovery, recurrent stroke, and mortality in patients with and without detected AF.
AF detection rate in this ESUS cohort was 12% over the study period. Patients with detected AF were associated with bilateral infarcts pattern at presentation (30% versus 5.5%, P = .035). Infarcts involving multiple vascular territories was not significantly associated with the detection of AF. There were no significant differences in the other clinical characteristics and outcomes between the AF group compared to the group without detected AF. Echocardiographic parameters including left ventricular ejection fraction and left atrial diameter were also not shown to be significantly different.
Our study found that a neuroimaging profile of bilateral infarcts was associated with AF detection using insertable cardiac monitor in ESUS patients. Larger prospective studies are needed to validate our findings.
可插入式心脏监测器(ICM)越来越多地用于检测不明原因卒中或来源不明的栓塞性卒中(ESUS)患者的房颤(AF)。我们旨在研究这些随后被发现患有房颤的患者的特征。
我们研究了83例连续患者,这些患者通过神经影像学和血管成像(计算机断层血管造影、磁共振血管造影或经颅和颅外多普勒超声检查)进行了全面评估,符合先前制定的ESUS标准。所有83例患者在2015年至2017年期间植入了ICM。所有患者均接受了至少1年的随访,中位随访期为1.5±0.5年。我们比较了有和没有检测到房颤的患者的基线临床、实验室、超声心动图、神经影像学特征以及功能恢复、复发性卒中和死亡率方面的临床结局。
在研究期间,该ESUS队列中的房颤检测率为12%。检测到房颤的患者在就诊时与双侧梗死模式相关(30%对5.5%,P = 0.035)。涉及多个血管区域的梗死与房颤的检测无显著相关性。与未检测到房颤的组相比,房颤组在其他临床特征和结局方面无显著差异。包括左心室射血分数和左心房直径在内的超声心动图参数也未显示出显著差异。
我们的研究发现,双侧梗死的神经影像学特征与ESUS患者使用可插入式心脏监测器检测房颤相关。需要更大规模的前瞻性研究来验证我们的发现。